Soffer DE - Search Results

1

Review of current evidence and clinical recommendations on the effects of low-carbohydrate and very-low-carbohydrate (including ketogenic) diets for the management of body weight and other cardiometabolic risk factors: A scientific statement from the National Lipid Association Nutrition and Lifestyle Task Force.

Kirkpatrick CF, Bolick JP, Kris-Etherton PM, Sikand G, Aspry KE, Soffer DE, Willard KE, Maki KC. Kirkpatrick CF, et al. Among authors: soffer de. J Clin Lipidol. 2019 Sep-Oct;13(5):689-711.e1. doi: 10.1016/j.jacl.2019.08.003. Epub 2019 Sep 13. J Clin Lipidol. 2019. PMID: 31611148 Free article. Review.

2

Enhancing the value of PCSK9 monoclonal antibodies by identifying patients most likely to benefit. A consensus statement from the National Lipid Association.

Robinson JG, Jayanna MB, Brown AS, Aspry K, Orringer C, Gill EA, Goldberg A, Jones LK, Maki K, Dixon DL, Saseen JJ, Soffer D. Robinson JG, et al. J Clin Lipidol. 2019 Jul-Aug;13(4):525-537. doi: 10.1016/j.jacl.2019.05.005. Epub 2019 May 16. J Clin Lipidol. 2019. PMID: 31281070

3

JCL Roundtable: From Gen Med to Clinical Lipidology.

Willard KE, Soffer D, Underberg JA, Guyton JR. Willard KE, et al. J Clin Lipidol. 2023 Mar-Apr;17(2):199-207. doi: 10.1016/j.jacl.2023.03.002. J Clin Lipidol. 2023. PMID: 36965957

4

A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice.

Koschinsky ML, Bajaj A, Boffa MB, Dixon DL, Ferdinand KC, Gidding SS, Gill EA, Jacobson TA, Michos ED, Safarova MS, Soffer DE, Taub PR, Wilkinson MJ, Wilson DP, Ballantyne CM. Koschinsky ML, et al. Among authors: soffer de. J Clin Lipidol. 2024 Mar 29:S1933-2874(24)00033-3. doi: 10.1016/j.jacl.2024.03.001. Online ahead of print. J Clin Lipidol. 2024. PMID: 38565461

5

Effect of lifestyle intervention on cardiometabolic risk factors: results of the POWER-UP trial.

Vetter ML, Wadden TA, Chittams J, Diewald LK, Panigrahi E, Volger S, Sarwer DB, Moore RH; POWER-UP Research Group. Vetter ML, et al. Int J Obes (Lond). 2013 Aug;37 Suppl 1(0 1):S19-24. doi: 10.1038/ijo.2013.92. Int J Obes (Lond). 2013. PMID: 23921777 Free PMC article. Clinical Trial.

6

Review of Cardiometabolic Effects of Prescription Omega-3 Fatty Acids.

Burke MF, Burke FM, Soffer DE. Burke MF, et al. Among authors: soffer de. Curr Atheroscler Rep. 2017 Nov 7;19(12):60. doi: 10.1007/s11883-017-0700-z. Curr Atheroscler Rep. 2017. PMID: 29116404 Review.

7

Case report: 68 yo Chinese-American woman with high HDL-C and ischemic stroke attributed to intracranial atherosclerotic stenosis.

Gong J, Asher SB, Cucchiara B, Cuchel M, Soffer D. Gong J, et al. J Clin Lipidol. 2021 Mar-Apr;15(2):248-254. doi: 10.1016/j.jacl.2021.01.006. Epub 2021 Jan 28. J Clin Lipidol. 2021. PMID: 33573892

8

Small interfering ribonucleic acid for cholesterol lowering - Inclisiran: Inclisiran for cholesterol lowering.

Soffer D, Stoekenbroek R, Plakogiannis R. Soffer D, et al. J Clin Lipidol. 2022 Sep-Oct;16(5):574-582. doi: 10.1016/j.jacl.2022.06.009. Epub 2022 Jun 28. J Clin Lipidol. 2022. PMID: 35909047 Free article. Review.

9

[No title available]

[No authors listed] [No authors listed] PMID: 37173160

10

Effects of pioglitazone on lipoproteins, inflammatory markers, and adipokines in nondiabetic patients with metabolic syndrome.

Szapary PO, Bloedon LT, Samaha FF, Duffy D, Wolfe ML, Soffer D, Reilly MP, Chittams J, Rader DJ. Szapary PO, et al. Arterioscler Thromb Vasc Biol. 2006 Jan;26(1):182-8. doi: 10.1161/01.ATV.0000195790.24531.4f. Epub 2005 Nov 10. Arterioscler Thromb Vasc Biol. 2006. PMID: 16284192 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page